PMC:7555630 / 8351-9736
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T9 | 175-179 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T10 | 610-616 | Body_part | denotes | mental | http://purl.org/sig/ont/fma/fma264279 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T5 | 175-179 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T78 | 94-102 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T79 | 104-140 | Disease | denotes | hypertension, cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0001302 |
T80 | 104-116 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T81 | 118-140 | Disease | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
T82 | 142-155 | Disease | denotes | renal disease | http://purl.obolibrary.org/obo/MONDO_0002118|http://purl.obolibrary.org/obo/MONDO_0005240 |
T84 | 157-165 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T85 | 175-187 | Disease | denotes | lung disease | http://purl.obolibrary.org/obo/MONDO_0005275 |
T86 | 656-664 | Disease | denotes | delirium | http://purl.obolibrary.org/obo/MONDO_0045057 |
T87 | 817-825 | Disease | denotes | dementia | http://purl.obolibrary.org/obo/MONDO_0001627 |
T88 | 875-886 | Disease | denotes | hypotension | http://purl.obolibrary.org/obo/MONDO_0005468 |
T89 | 971-988 | Disease | denotes | movement disorder | http://purl.obolibrary.org/obo/MONDO_0005395 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T37 | 175-179 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T38 | 175-179 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T39 | 283-285 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
T40 | 789-790 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T41 | 846-848 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T7 | 433-438 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T8 | 1213-1231 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T9 | 1249-1260 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T10 | 1293-1303 | Chemical | denotes | adamantane | http://purl.obolibrary.org/obo/CHEBI_40519 |
T11 | 1353-1363 | Chemical | denotes | amantadine | http://purl.obolibrary.org/obo/CHEBI_2618 |
T12 | 1374-1383 | Chemical | denotes | memantine | http://purl.obolibrary.org/obo/CHEBI_64312 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T53 | 104-116 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T54 | 118-140 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T55 | 167-187 | Phenotype | denotes | chronic lung disease | http://purl.obolibrary.org/obo/HP_0006528 |
T56 | 635-643 | Phenotype | denotes | lethargy | http://purl.obolibrary.org/obo/HP_0001254 |
T57 | 656-664 | Phenotype | denotes | delirium | http://purl.obolibrary.org/obo/HP_0031258 |
T58 | 666-680 | Phenotype | denotes | hallucinations | http://purl.obolibrary.org/obo/HP_0000738 |
T59 | 685-697 | Phenotype | denotes | bradyphrenia | http://purl.obolibrary.org/obo/HP_0031843 |
T60 | 817-825 | Phenotype | denotes | dementia | http://purl.obolibrary.org/obo/HP_0000726 |
T61 | 875-886 | Phenotype | denotes | hypotension | http://purl.obolibrary.org/obo/HP_0002615 |
T62 | 925-950 | Phenotype | denotes | abnormalities of movement | http://purl.obolibrary.org/obo/HP_0100022 |
T63 | 971-988 | Phenotype | denotes | movement disorder | http://purl.obolibrary.org/obo/HP_0100022 |
T64 | 1031-1051 | Phenotype | denotes | generalized weakness | http://purl.obolibrary.org/obo/HP_0003324 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T56 | 0-263 | Sentence | denotes | Twenty-eight patients (78%) had at least one of six comorbidities associated with more severe COVID-19 (hypertension, cardiovascular disease, renal disease, diabetes, chronic lung disease, or immunosuppression), with the majority having more than one risk factor. |
T57 | 264-452 | Sentence | denotes | Thirteen patients (36%) lived in their own home, while twenty-three (64%) were at extended care facilities: nursing home (n = 17), assisted living facility (n = 5), and group home (n = 1). |
T58 | 453-544 | Sentence | denotes | Their presentation, clinical course, management, and outcome are also presented in Table 1. |
T59 | 545-755 | Sentence | denotes | Of interest, twenty-seven patients (75%) exhibited alteration in mental status (including lethargy, confusion, delirium, hallucinations, or bradyphrenia), and in twenty-two (61%), it was the presenting symptom. |
T60 | 756-826 | Sentence | denotes | Of these, only fifteen (56%) had a pre-existing diagnosis of dementia. |
T61 | 827-951 | Sentence | denotes | Thirteen patients (36%) were documented to have hypotension, and fifteen (42%) were noted to have abnormalities of movement. |
T62 | 952-1136 | Sentence | denotes | Worsening of their movement disorder was reported by seven patients (19%), and generalized weakness or worsening mobility were noted as the presenting symptom by eleven patients (31%). |
T63 | 1137-1189 | Sentence | denotes | Twenty-four patients (67%) required hospitalization. |
T64 | 1190-1261 | Sentence | denotes | Nine patients received hydroxychloroquine and two received oseltamivir. |
T65 | 1262-1385 | Sentence | denotes | Six patients were receiving an adamantane as part of their neurologic management (three on amantadine, three on memantine). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
284 | 13-21 | Species | denotes | patients | Tax:9606 |
285 | 273-281 | Species | denotes | patients | Tax:9606 |
286 | 571-579 | Species | denotes | patients | Tax:9606 |
287 | 836-844 | Species | denotes | patients | Tax:9606 |
288 | 1011-1019 | Species | denotes | patients | Tax:9606 |
289 | 1121-1129 | Species | denotes | patients | Tax:9606 |
290 | 1149-1157 | Species | denotes | patients | Tax:9606 |
291 | 1195-1203 | Species | denotes | patients | Tax:9606 |
292 | 1266-1274 | Species | denotes | patients | Tax:9606 |
293 | 1213-1231 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
294 | 1249-1260 | Chemical | denotes | oseltamivir | MESH:D053139 |
295 | 1293-1303 | Chemical | denotes | adamantane | MESH:D000218 |
296 | 1353-1363 | Chemical | denotes | amantadine | MESH:D000547 |
297 | 1374-1383 | Chemical | denotes | memantine | MESH:D008559 |
298 | 94-102 | Disease | denotes | COVID-19 | MESH:C000657245 |
299 | 104-116 | Disease | denotes | hypertension | MESH:D006973 |
300 | 118-140 | Disease | denotes | cardiovascular disease | MESH:D002318 |
301 | 142-155 | Disease | denotes | renal disease | MESH:D007674 |
302 | 157-165 | Disease | denotes | diabetes | MESH:D003920 |
303 | 175-187 | Disease | denotes | lung disease | MESH:D008171 |
304 | 635-643 | Disease | denotes | lethargy | MESH:D053609 |
305 | 656-664 | Disease | denotes | delirium | MESH:D003693 |
306 | 666-680 | Disease | denotes | hallucinations | MESH:D006212 |
307 | 685-697 | Disease | denotes | bradyphrenia | |
308 | 817-825 | Disease | denotes | dementia | MESH:D003704 |
309 | 875-886 | Disease | denotes | hypotension | MESH:D007022 |
310 | 971-988 | Disease | denotes | movement disorder | MESH:D009069 |
311 | 1043-1051 | Disease | denotes | weakness | MESH:D018908 |